Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1051👍, 0💬
Related Topics:
Popular Posts:
How to download the research paper with a given DOI number? If you know the DOI (Digital Object Iden...
Paper Summary: DOI: 10.1002/rmv.2471 Received on: 2024-06-13
Paper Summary: DOI: 10.1037/dhe0000528 Received on: 2024-03-11
Paper Summary: DOI: 10.1038/s42255-022-00575 -zReceived on: 2024-06-03
Paper Summary: DOI: 10.1103/PhysRevB.109.024 434Received on: 2024-03-03
